Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Peficitinib Hydrobromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 52,156Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Asp015k hydrobromide, Asp-015k hydrobromide, Peficitinib hydrobromide [usan], U55xhz5x6p, 1353219-05-2, 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((anti-5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, hydrobromide (1:1)
    Molecular Formula
    C18H23BrN4O2
    Molecular Weight
    407.3  g/mol
    InChI Key
    ZUVPMAPXNYGJQC-OGTXJUTESA-N
    FDA UNII
    U55XHZ5X6P
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[[(1S,3R)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide;hydrobromide
    2.1.2 InChI
    InChI=1S/C18H22N4O2.BrH/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10;/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22);1H/t9?,10-,11+,14?,18?;
    2.1.3 InChI Key
    ZUVPMAPXNYGJQC-OGTXJUTESA-N
    2.1.4 Canonical SMILES
    C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O.Br
    2.1.5 Isomeric SMILES
    C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O.Br
    2.2 Other Identifiers
    2.2.1 UNII
    U55XHZ5X6P
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Asp015k Hydrobromide

    2. Asp-015k Hydrobromide

    3. Peficitinib Hydrobromide [usan]

    4. U55xhz5x6p

    5. 1353219-05-2

    6. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((anti-5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1)

    7. Asp 015k Hydrobromide

    8. Unii-u55xhz5x6p

    9. Smyraf (tn)

    10. Schembl9990237

    11. Chembl3137329

    12. Schembl14876111

    13. Schembl14876113

    14. Peficitinib Hydrobromide (jan/usan)

    15. Peficitinib Hydrobromide [who-dd]

    16. D10721

    17. Q27290703

    18. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1), Stereoisomer

    19. 4-(((1r,2s,3s,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1h-pyrrolo(2,3-b)pyridine-5-carboxamide Monohydrobromide

    2.4 Create Date
    2012-11-30
    3 Chemical and Physical Properties
    Molecular Weight 407.3 g/mol
    Molecular Formula C18H23BrN4O2
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count3
    Exact Mass406.10044 g/mol
    Monoisotopic Mass406.10044 g/mol
    Topological Polar Surface Area104 Ų
    Heavy Atom Count25
    Formal Charge0
    Complexity525
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2